nicardipine has been researched along with pilocarpine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ikegaya, Y; Matsuki, N; Nishiyama, N | 1 |
| Evans, V; Millar, TJ; Willcox, MD | 1 |
| Buckmaster, PS; Ingram, EA; Toyoda, I; Wen, X | 1 |
1 review(s) available for nicardipine and pilocarpine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for nicardipine and pilocarpine
| Article | Year |
|---|---|
Modulation of tear film protein secretion with phosphodiesterase inhibitors.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Blotting, Western; Double-Blind Method; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Eye Proteins; Female; Gels; Humans; Lacrimal Apparatus; Male; Nicardipine; Phosphodiesterase Inhibitors; Pilocarpine; Safety; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tears | 2000 |
3 other study(ies) available for nicardipine and pilocarpine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
L-type Ca(2+) channel blocker inhibits mossy fiber sprouting and cognitive deficits following pilocarpine seizures in immature mice.
Topics: Animals; Animals, Newborn; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Cognition Disorders; Excitatory Postsynaptic Potentials; Male; Mice; Mossy Fibers, Hippocampal; Motor Activity; Muscarinic Agonists; Nicardipine; Pilocarpine; Seizures | 2000 |
Prolonged infusion of inhibitors of calcineurin or L-type calcium channels does not block mossy fiber sprouting in a model of temporal lobe epilepsy.
Topics: Animals; Blotting, Western; Calcineurin Inhibitors; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclosporine; Epilepsy, Temporal Lobe; Immunosuppressive Agents; Male; Mossy Fibers, Hippocampal; Muscarinic Agonists; Nicardipine; Pilocarpine; Rats; Rats, Sprague-Dawley; Tacrolimus; Time Factors | 2009 |